Eyal Desheh

Eyal Desheh is an Independent Board Member at CytoReason. Eyal was previously the Chairman of the Board at Isracard from July 2017 to November 2020. Prior to that, they were a Board Member at Mobileye from January 2013 to December 2017, and at Stratasys from January 2011 to December 2016. From April 2008 to July 2017, they were the Executive Vice President CFO at Teva Pharmaceuticals.

Eyal Desheh has a Master of Business Administration - MBA from The Hebrew University of Jerusalem and a Bachelor's degree in Economics from The Hebrew University of Jerusalem.